- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 154
FreeWire gets $25m transmission
BP Ventures led a series B equity and debt round for the charger provider that also featured another corporate investor, ABB Technology Ventures.
Apr 24, 2020Leuven Instruments loops in series B financing
Red Star Macalline was among the participants in a $14.1m round for the semiconductor production equipment maker that will fund hiring and product development.
Apr 24, 2020Tridge tracks $11m for series B
Forest Partners and Activant Capital have invested $11m in the SoftBank-backed agriculture trading hub.
Apr 23, 2020Fonterra helps cook up YFood series B
The dairy cooperative was among the investors in a $16.3m round that will help nutrious drink brand YFood expand further into Europe.
Apr 23, 2020Goldman Sachs lifts Paige’s series B to $50m
Paige.ai has now raised $75m to date, with the latest funding set to help refine its cancer pathology software offering.
Apr 23, 2020Cloudbreak gets Grand investment
Grand Pharmaceutical invested $5.6m in Cloudbreak through a licensing agreement, as part of a $25.4m round for the ocular disorder therapy developer.
Apr 21, 2020Corporate venturing deal net: 13-17 April 2020
Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.
Apr 17, 2020Ichikara carries in series B funding
Itochu and Sony Music Entertainment backed a $17.7m round for the virtual entertainment provider that will go to talent acquisition and business development.
Apr 15, 2020Cerevance clears $45m series B
GV and Takeda have backed a series B round that will fund the Rockefeller University spinout's identification of targets for brain disease treatments.
Apr 15, 2020Cerevance clears $45m series B
GV and returning investor Takeda Ventures chipped into a series B round that will fund the identification of targets for brain disease treatments.
Apr 15, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


